|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Hydralazine#Package and Label Display Panel]] |
| {{Hydralazine}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==Labels and Packages==
| |
| | |
| PRINCIPAL DISPLAY PANEL
| |
| | |
| {|
| |
| | [[image:hydra3.jpg|400px|thumb]]
| |
| |}
| |
| | |
| Hydralazine Hydrochloride Tablets USP 10 mg 100s Label Text | |
| | |
| NDC 50111-398-01
| |
| | |
| HydrALAZINE
| |
| HYDROCHLORIDE
| |
| Tablets USP
| |
| 10 mg
| |
| | |
| Rx only
| |
| | |
| 100 TABLETS
| |
| | |
| TEVA
| |
| | |
| PRINCIPAL DISPLAY PANEL
| |
| {|
| |
| | [[image:hydra4.jpg|400px|thumb]]
| |
| |}
| |
| | |
| Hydralazine Hydrochloride Tablets USP 25 mg 100s Label Text
| |
| | |
| NDC 50111-327-01
| |
| | |
| HydrALAZINE
| |
| HYDROCHLORIDE
| |
| Tablets USP
| |
| 25 mg
| |
| | |
| Rx only
| |
| | |
| 100 TABLETS
| |
| | |
| TEVA
| |
| | |
| PRINCIPAL DISPLAY PANEL
| |
| | |
| {|
| |
| | [[image:hydra5.jpg|400px|thumb]]
| |
| |}
| |
| | |
| | |
| Hydralazine Hydrochloride Tablets USP 50 mg 100s Label Text
| |
| | |
| NDC 50111-328-01
| |
| | |
| HydrALAZINE
| |
| HYDROCHLORIDE
| |
| Tablets USP
| |
| 50 mg
| |
| | |
| Rx only
| |
| | |
| 100 TABLETS
| |
| | |
| TEVA
| |
| | |
| PRINCIPAL DISPLAY PANEL
| |
| | |
| {|
| |
| | |
| | [[image:hydra6.jpg|400px|thumb]]
| |
| | |
| |}
| |
| | |
| Hydralazine Hydrochloride Tablets USP 100 mg 100s Label Text
| |
| | |
| NDC 50111-397-01
| |
| | |
| HydrALAZINE
| |
| HYDROCHLORIDE
| |
| Tablets USP
| |
| 100 mg
| |
| | |
| Rx only
| |
| | |
| 100 TABLETS
| |
| | |
| TEVA<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbbdb09-3202-42d7-bbb0-08331dde2f54 | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |